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A B S T R A C T
Objective: The aim of this review was to synthesise the literature on the use of the Toronto Alexithymia Scale
(TAS) in eating disorder populations and Healthy Controls (HCs) and to compare TAS scores in these groups.
Method: Electronic databases were searched systematically for studies using the TAS and meta-analyses were
performed to statistically compare scores on the TAS between individuals with eating disorders and HCs.
Results: Forty-eight studies using the TAS with both a clinical eating disorder group and HCs were identiﬁed. Of
these, 44 were included in the meta-analyses, separated into: Anorexia Nervosa; Anorexia Nervosa, Restricting
subtype; Anorexia Nervosa, Binge-Purge subtype, Bulimia Nervosa and Binge Eating Disorder. For all groups,
there were signiﬁcant diﬀerences with medium or large eﬀect sizes between the clinical group and HCs, with the
clinical group scoring signiﬁcantly higher on the TAS, indicating greater diﬃculty with identifying and labelling
emotions.
Conclusion: Across the spectrum of eating disorders, individuals report having diﬃculties recognising or de-
scribing their emotions. Given the self-report design of the TAS, research to develop and evaluate treatments and
clinician-administered assessments of alexithymia is warranted.
1. Introduction
Alexithymia, meaning literally “no words for mood” [1] was ﬁrst
coined in the 1970s to deﬁne an inability to describe and/or recognise
one's own emotions. Since then, research has focused on both under-
standing alexithymia and on measuring it in both clinical and general
populations. Alexithymia is known to be present in several psychiatric
disorders, including depression [2]; Obsessive-Compulsive Disorder
[3]; Schizophrenia [4]; Post-Traumatic Stress Disorder [5]; Autism
Spectrum Disorder [6] and eating disorders (EDs) [e.g., 7]. While
alexithymia is described as a stable personality trait [8] it correlates
highly with symptoms of both depression and anxiety and may be a
predisposing factor for the development of other psychopathologies [9].
What's more, alexithymia is thought to underlie emotional diﬃculties
in individuals with eating disorders [10] and has been implicated in
both the development and maintenance of EDs [11]. It is also related to
poorer treatment outcome, making it a relevant treatment target [12].
Prevalence estimates of alexithymia within the general population,
as measured by the twenty-item Toronto Alexithymia Scale [TAS-20;
13], range from 5.2 to 18.8%, with a prevalence of 18% being reported
in a British undergraduate sample [14]. In this study, alexithymia was
found be to be more prevalent in females than in males. Alexithymia is
also associated with higher levels of sub-clinical disordered eating in
undergraduate females [15], mirroring what has been found in ED
populations [16–18].
One of the main focuses of alexithymia research has been how to
eﬀectively measure the concept. The development of the TAS-20 [13]
resulted in increased interest in this ﬁeld as it provides an eﬃcient way
to measure alexithymia, allowing for comparability across clinical
groups [9]. The TAS-20 is a brief, self-report measure on which parti-
cipants rate their level of agreement to statements on a ﬁve-point Likert
scale, yielding a total score as well as subscale scores designed to
measure: diﬃculty identifying feelings (DIF); diﬃculty describing
feelings (DDF) and externally-oriented thinking (EOT). The maximum
possible score on the TAS-20 is 100 with a score of 61 or above in-
dicative of high levels of alexithymia [19]. The TAS-20 demonstrates
good reliability and factorial validity [20,21]. Despite the TAS being
widely used, normative data for ED populations have not yet been
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reported. Synthesising studies comparing scores on the TAS in ED
groups with Healthy Controls (HCs) would therefore aid comparison
between existing and future studies.
The TAS-20 has been criticised for not measuring a universal alex-
ithymia construct but perhaps instead measuring concepts such as so-
cial shame [22], negative emotional expressivity [23] or negative aﬀect
[24]. The factor structure of the TAS-20 may also vary across samples
[25], highlighting the need to use the TAS-20 in combination with other
measures of alexithymia [26]. Disagreement exists over exactly which
constructs instruments are measuring and there is still a need for reli-
able, objective measures of alexithymia for use across psychiatric po-
pulations. Determining whether individuals with EDs consistently score
higher on the TAS than controls would be useful for future research,
aiming to develop new ways of measuring alexithymia in this popula-
tion.
In a critical review of the literature on alexithymia in EDs,
Nowakowski, McFarlane [18] report that individuals with EDs con-
sistently report higher levels of alexithymia on the TAS than controls.
However, as this review did not include meta-analysis of studies, it is
not known whether the eﬀect size is the same across the spectrum of
EDs, e.g., in Anorexia Nervosa (AN), Bulimia Nervosa (BN) or Binge ED
(BED), or whether a particular diagnosis is associated with higher levels
of alexithymia. Nowakowski, McFarlane [18] report that individuals
with EDs score higher on two of the TAS-20 subscales: DDF and DIF but
not on EOT. Performing meta-analyses of subscale scores will help
synthesise this literature further and to determine whether signiﬁcant
diﬀerences exist between groups on all sub-scale scores.
1.1. Aims of the study
This review aimed to synthesis the literature on the use of the
Toronto Alexithymia Scale to assess alexithymia across the spectrum of
eating disorder and to compare total and sub-scale scores on the
Toronto Alexithymia Scale between eating disorder diagnoses.
2. Method
The systematic review and meta-analysis was conducted according
to the PRISMA statement [27]. The quality of each study was assessed
using the Clinical Appraisal Skills Programme checklist for case–control
studies [28]. The tool consists of 11 questions, which yield a mixture of
‘yes’, ‘no’ and more qualitative answers. In this review, extra questions
were added to more fully appraise the speciﬁc qualities of studies ad-
dressing alexithymia in EDs. These included whether confounding
variables were accounted for in analysis and whether association be-
tween the TAS scores and other psychopathologies was examined. To
calculate an overall quality rating, several questions were split into sub
questions and a score of 1 was awarded for every ‘yes’ answered, with a
maximum possible score of 17. The quality rating for each study is
shown in Table 1.
2.1. Eligibility criteria
Studies using either the TAS-20 or TAS-26 with both a clinical ED
population and HCs were included in the review. Inclusion criteria
were: 1) full text available in English; 2) reporting mean and standard
deviation TAS total scores for both groups; 3) published in a peer-re-
viewed journal.
2.2. Information sources and search
The electronic databases PsychInfo, Scopus, Pubmed and Web of
Science were searched systematically for papers up to and including
May 2017. The search terms were either Anorexia Nervosa, Bulimia
Nervosa or ED and alexithymia or Toronto Alexithymia Scale. With the
exception of being published in a peer-reviewed journal, no other
search limits were applied. The reference list of a previously published
review [18] was also screened for relevant studies.
2.3. Selection
The titles of papers were screened for relevance and the abstracts of
those that appeared to meet the criteria were then screened by both the
ﬁrst and second authors. Full texts were retrieved if the abstract in-
dicated that the inclusion criteria had been met or if the details of the
study were ambiguous. The ﬁrst and second author discussed all full-
texts and reached consensus about whether to include them in the re-
view. Any full-texts which did not meet the inclusion criteria were
excluded. The number of papers reviewed at each stage of the review
process, including reasons for exclusion at full-text screening, is dis-
played in Fig. 1.
2.4. Data collection and items
The following data were extracted from each included paper: di-
agnosis of clinical group; mean age; mean BMI; mean ED duration; how
the clinical and HC groups were matched; TAS version; mean TAS
scores, including subscale scores if the TAS-20 was used; recruitment
site; percentage of female participants; diagnostic tool used and any co-
morbidities which were assessed.
2.5. Risk of bias in individuals studies
Risk of bias within each study was assessed by considering how the
methodology may impact on the results i.e., how clinical groups were
matched to HCs, where participants were recruited from and how ED
pathology was assessed.
2.6. Summary measure
The principle measure used for meta-analysis was the diﬀerence in
mean scores and standard deviations on the TAS and any reported
subscale scores.
2.7. Synthesis of data
For the purposes of meta-analyses, studies were split into diﬀerent
ED diagnoses: AN; AN binge-purge type (AN-BP); AN restricting type
(AN-R), BN and BED. Studies which included more than one diagnostic
group e.g. AN and BN as well as HCs were included in each respective
meta-analysis separately. The meta-analyses were performed by pooling
the standard eﬀect sizes using a random eﬀects model. This model as-
sumes that as well as within-group variability in scores, mean eﬀect size
is also caused by diﬀerences between studies. The random-eﬀects model
includes between study heterogeneity, resulting in estimates with wider
conﬁdence intervals than ﬁxed-eﬀect models. Individual meta-analyses
were also run for each of the TAS-20 subscale scores, again split into
diﬀerent diagnostic groups.
2.8. Statistical analysis
All meta-analyses were conducted using Review Manager 5.3 [29].
Cohen's d [30] was used to estimate eﬀect sizes using the following
interpretation: small (0.2), medium (0.5) and large (0.8). Positive eﬀect
sizes indicate that the clinical group scored higher on the TAS than the
control group. A p value of< 0.05 indicates a signiﬁcant diﬀerence
between the clinical group and HCs. To assess the potential impact of
moderator variables on the results of the meta-analysis, meta-regression
was performed using STATA 13 [31] with the following user-con-
tributed command: metreg [32].
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2.9. Risk of bias across studies
Publication bias was assessed visually by inspection of funnel plots,
which represent a plot of a study's precision (1/standard error) against
eﬀect size. The absence of studies in the right bottom corner (low
precision and small eﬀect sizes) of a funnel plot is usually taken as an
indication of publication bias. The Duval and Tweedie [33] non-para-
metric ‘trim and ﬁll’ method was also used, which accounts for pub-
lication bias in meta-analysis as implemented in Stata's user-written
command ‘metatrim’ [34]. Eﬀect sizes following adjustment for the
publication bias using the trim and ﬁll method are reported. It was
noted that the eﬀect size of one study [35] was extremely large, re-
presenting an outlier in the AN meta-analysis. The original data were
checked and had been reported incorrectly in the paper (standard de-
viations of the AN and HC groups were incorrect) and have therefore
been updated here accordingly.
Between-study heterogeneity was measured using I2 [36] based on
Cochran's Q test: measure of heterogeneity, I2 = 100%× (Q-df)/Q,
where df is degrees of freedom. I2 ranges between 0%, indicating no
heterogeneity and 100%, indicating high heterogeneity with the fol-
lowing approximate interpretation: 0 to 40% might not be important;
30 to 60%, moderate heterogeneity; 50 to 90% may represent sub-
stantial heterogeneity and 75 to 100% is considerable heterogeneity
[37].
2.10. Additional analysis
To examine the potential predictors of between study heterogeneity,
age or BMI measures were assessed to examine whether they could
explain some of the variance using meta-regressions. Mean age of the
clinical and control group and the mean age diﬀerence between clinical
and control group were used as predictor variables. To assess BMI, BMI
of the clinical group and BMI diﬀerences between clinical and control
group were used. For each domain, three models were assessed: mean
age, age diﬀerence and mean age and age diﬀerence and mean clinical
BMI, BMI diﬀerence and mean clinical and BMI diﬀerence, respectively.
3. Results
3.1. Study selection
A total of 48 studies were identiﬁed through systematic review of
the literature. Of these studies, three [24,38,39] include a mixed ED
sample i.e., patients with either AN, BN or BED and one study [40]
included only patients who had recovered from AN. These subgroups of
studies were too small to be included in meta-analysis, leaving 44
studies to be included in further analysis. Rommel, Nandrino [41] in-
cluded an AN-R and a mixed AN-BP/BN group with purging symptoms,
therefore, only the AN-R group was included in the corresponding
meta-analysis as the mixed group could not be compared to either AN-
BP or BN groups in other studies.
3.2. Study characteristics
All extracted information included in the systematic review and
meta-analyses is presented in Table 1. Generally, the quality of re-
porting within individual studies was high. All studies included the
mean age of participants, aside from Speranza, Corcos [42] who did not
report the mean age of HCs. Twelve studies did not report the mean BMI
or percentage of ideal body weight (%IBW) for at least one participant
group. Half of the studies identiﬁed (N = 22) did not report the dura-
tion of illness in the clinical ED group. Sixteen studies did not describe
how HCs were matched to the clinical group while one study reported
the groups being matched by “sociodemographic characteristics”
without being more speciﬁc [43]. The most common characteristic on
which groups were matched was age (N = 29) and 24 studies matchedT
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groups on at least two characteristics. Twenty-six studies included at
least one group with a sample size of< 30.
Out of a maximum score of 17 on the quality appraisal, three studies
scored 16 [44–46]. The study with the lowest overall quality rating was
Deborde, Berthoz [39], which did not include any information on how
participants were recruited, inclusion/exclusion criteria, any con-
founding factors which may have inﬂuence the results, the relationship
between TAS scores and other variables or the precision or gen-
eralisability of the results. All other studies scored between 11 and 15.
Eleven studies used the TAS-26 while the remaining 37 studies used
the 20-item version. Of the studies using the TAS-20, 20 reported scores
for the three subscales while two [46,47] included subscale scores for
DIF and DDF but not EOT, due to poor internal consistency of this factor
within the study. Seven studies did not report where at least one of the
groups (clinical or HC) was recruited from and 14 studies did not
provide details of how EDs were diagnosed. Co-morbid mental health
problems were assessed in all but nine of the included studies, with
symptoms of depression and anxiety being the most commonly as-
sessed. Except for Marchesi, Ossola [24], whose ED and HCs samples
was 92.3% and 80.8% female respectively and Aloi, Rania [48] whose
BED and HC groups were 45% and 81.4% respectively, all studies in-
cluded only female participants. Tchanturia, Davies [49] did not
explicitly report the sex of their participants.
Twenty-two studies attempted to control for potential confounding
variables within analysis, 19 of which controlled for depression. After
controlling for depression, the diﬀerence in TAS scores between the
clinical group and HCs remained signiﬁcant in eight studies. In the
other studies, the diﬀerence was either no longer signiﬁcant or was only
signiﬁcant on certain subscales of the TAS or for subgroups of partici-
pants. Thirty-four studies also examined correlations between TAS
scores and other variables, including depression, anxiety, BMI and ill-
ness duration, of which 15 studies reported a signiﬁcant positively
correlation between TAS scores and depression in their respective
clinical groups. More information on the results of the quality appraisal
are presented in the appendix.
3.3. Risk of bias
The funnel plots for AN, AN-R, AN-BP, BN and BED studies are
shown in Figs. 2–6. In all ﬁve study groups, there was some evidence of
publication bias as there was a small asymmetrical appearance of the
funnel plots with a gap in the left bottom corner of the graph, indicating
that smaller eﬀect sized studies with less precision may be missing. The
trim and ﬁll method indicated missing studies in all ﬁve groups. The re-
Fig. 1. Systematic review search process.
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estimated eﬀect sizes decreased but remained signiﬁcant (p < 0.001)
or almost signiﬁcant (BED: p = 0.065), (AN: 1.08 (95% CI 0.83, 1.33),
AN-R: 10.94 (95% CI 0.65, 1.24), AN-BP: 1.89 (95% CI 0.39, 1.1.39),
BN: 0.90 (95% CI 0.64, 1.16), BED: 0.44 (95% CI −0.3, 0.92,
p = 0.065)).
3.4. Synthesis of results
The forest plot of studies including participants with AN is displayed
in Fig. 7. The random-eﬀect analysis with a total sample size of 2332
participants (AN = 944, HC = 1388) from 22 studies revealed a sig-
niﬁcant diﬀerence with a large eﬀect size between AN and HC groups
on the total TAS score (d= 1.44, (95% CI 1.2, 1.68) z = 12.01,
p < 0.001). For studies in which AN subtype was deﬁned, the forest
plots are displayed in Fig. 8. For AN-R studies, the analysis with a total
sample size of 1159 participants (AN-R = 441, HC = 718) from 12
studies revealed a signiﬁcant diﬀerence between groups, again with a
large eﬀect size (d= 1.18, (95% CI 0.90, 1.46) z = 8.22, p < 0.001).
For AN-BP studies, the analysis with a total sample size of 720 parti-
cipants (AN-BP = 177, HC = 543) from six studies revealed a sig-
niﬁcant diﬀerence with large eﬀect size (d= 1.25, (95% CI 0.79, 1.72)
z = 5.33, p < 0.001). The forest plot of BN studies is displayed in
Fig. 9. The analysis included a total of 2391 participants (BN = 858,
HC = 1533) from 21 studies and revealed a signiﬁcant diﬀerence with
a large eﬀect size between the two groups (d= 1.26, (95% CI 1.02,
1.51) z = 10.07, p < 0.001). The forest plot for BED studies is dis-
played in Fig. 10. The analysis included a total of 488 participants
(BED = 192, HC = 296) from ﬁve studies and revealed a signiﬁcant
Fig. 2. Funnel plot of Anorexia Nervosa (AN) studies included in the meta-analysis to
assess for publication bias. Each dot represents a study included in the meta-analysis, with
the Y axis representing the size of each study and the X axis, each study's result.
Fig. 3. Funnel plot of Anorexia Nervosa, Restricting subtype (AN-R) studies included in
the meta-analysis to assess for publication bias. Each dot represents a study included in
the meta-analysis, with the Y axis representing the size of each study and the X axis, each
study's result.
Fig. 4. Funnel plot of Anorexia Nervosa, Binge-Purge subtype (AN-BP) studies included in
the meta-analysis to assess for publication bias. Each dot represents a study included in
the meta-analysis, with the Y axis representing the size of each study and the X axis, each
study's result.
Fig. 5. Funnel plot of Bulimia Nervosa (BN) studies included in the meta-analysis to as-
sess for publication bias. Each dot represents a study included in the meta-analysis, with
the Y axis representing the size of each study and the X axis, each study's result.
Fig. 6. Funnel plot of Binge Eating Disorder (BED) studies included in the meta-analysis
to assess for publication bias. Each dot represents a study included in the meta-analysis,
with the Y axis representing the size of each study and the X axis, each study's result.
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diﬀerences with a medium eﬀect size between the two groups
(d= 0.76, (95% CI 0.31, 1.21) z = 3.32, p < 0.001).
3.5. TAS-20 subscale analysis
The forest plots for TAS-20 subscale analysis are shown in
Figs. 11–13. For AN studies, the random-eﬀect analysis included a total
sample size of 1642 (AN = 635, HC = 1007) from 13 studies for the
DIF and DDF subscales. For the DIF subscale, there was a signiﬁcant
diﬀerence between groups with a large eﬀect size (d= 1.57, (95% CI
1.33, 1.80) z = 13.1933, p < 0.001). For the DDF subscale, there was
also a signiﬁcant diﬀerence between groups with a large eﬀect size
(d= 1.11, (95% CI 0.93, 1.29) z = 12.14, p < 0.001). For the EOT
subscale, the analysis included 1509 participants (AN = 582,
HC = 927) from 12 studies. For the EOT subscale, there was a sig-
niﬁcant diﬀerence between groups with a small eﬀect size (d= 0.48,
(95% CI 0.23, 0.74) z = 3.73, p < 0.001).
For AN-R studies, the meta-analysis of the DIF and DDF subscales
included a total of 833 participants (AN-R = 301, HC = 532). As was
the case in the AN studies, there were signiﬁcant diﬀerences between
the groups on the DIF (d= 1.15, (95% CI 1.00, 1.31), z = 14.4,
p < 0.001) and DDF (d= 0.89, (95% CI 0.61, 1.16) subscales with
large eﬀect sizes. The analysis for the EOT subscale, consisting of a total
sample size of 701 (AN-R= 249, HC = 452) revealed that there was no
signiﬁcant diﬀerence between groups (d= 0.08, (95% CI -0.18, 0.34)
z = 0.58, p = 0.56). As only three studies including participant with
AN-BP reported TAS-20 subscale scores, meta-analysis could not be run
for this diagnostic group.
For BN, the analysis for the DIF and DDF subscales consisted of a
total sample size of 1400 (BN = 400, HC = 1000) from eight studies.,
There were signiﬁcant diﬀerences with large eﬀect size between groups
on both the DIF (d= 1.58, (95% CI 1.29, 1.87) z = 10.80, p < 0.001)
and the DDF (d= 0.89, (95% CI 0.57, 1.21) z = 5.49, p < 0.001)
subscale scores. There was no diﬀerence between the groups on the
EOT subscale score (d= 0.02 (95% CI −0.24, 0.27) z = 0.14,
p = 0.89).
Fig. 7. Forest plot of mean TAS score: standardized mean eﬀect
size for diﬀerences (SMD) between Anorexia Nervosa (AN) and
Healthy Controls. CI, conﬁdence interval.
Fig. 8. Forest plot of mean TAS score: standardized mean eﬀect
size for diﬀerences (SMD) between Anorexia Nervosa,
Restricting subtype (AN-R) and Healthy Controls (HC) and be-
tween Anorexia Nervosa, Binge-Purge subtype (AN-BP) and HCs.
CI, conﬁdence interval.
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3.6. Additional analysis
There was evidence of substantial heterogeneity in the overall TAS
score analysis for all diagnostic groups (AN, I2 = 81%; AN-R, I2 = 74%,
AN-BP, I2 = 80%; BN, I2 = 82%, BED, I2 = 78%). To examine the
potential cause of this heterogeneity, meta-regression was performed
with BMI of the clinical group, diﬀerences in BMI between clinical and
control group, mean age and age diﬀerence between clinical and con-
trol group as moderator variables. Meta regressions revealed that BMI
of the clinical groups or the diﬀerence in BMI between clinical and
control group revealed that only in the AN group there was a signiﬁcant
positive eﬀect of BMI diﬀerence on eﬀect size (b = 0.21 (95% CI 0.03,
0.38), t = 2.56, p = 0.023) However, the eﬀect remained signiﬁcant at
the mean diﬀerence (d= 1.10 (95% CI 0.66, 1.53), t = 5.43,
p < 0.001 (all other p's > 0.1). There was a signiﬁcant eﬀect of mean
age on outcome in AN and BN (AN: b = 0.10 (95% CI 0.05, 0.16),
t = 3.91, p = 0.001, N = 22; BN: b = 0.09 (95% CI 0.003, 0.18),
t = 2.19, p = 0.042, N = 21) but not for age diﬀerence between clin-
ical and control groups (AN: b = 0.02 (95% CI−0.20, 0.23), t = 0.18,
p = 0.86, N = 21; BN: 0.002 (95% CI −0.10, 0.11), t = 0.05,
p = 0.96, N = 20). The eﬀect of age was usually (not in BED) smaller
and not signiﬁcant in AN-R (b = 0.01 (95% CI−0.34, 0.36), t = 0.06,
p = 0.96, N = 6) or AN-BP (b = 0.05 (95% CI−0.07, 0.18), t = 0.93,
p = 0.38, N = 12) or BED b = 0.17(−0.1–0.44) t = 2.06, p = 0.13
and age diﬀerence was not signiﬁcant: AN-R: b =−0.09 (95% CI
−0.37, 0.18), t =−0.93, p = 0.40, N = 6; AN-BP: b =−0.04 (95%
CI −0.17, 0.10), t =−0.59, p = 0.57, N = 12 or BED b =−0.01
(95% CI −24, −0.21), t =−0.19, p = 0.86, N= 5. Conclusions did
not change if both variables were modelled together in a multiple re-
gression (AN: age: b = 0.11 (95% CI 0.05, 0.17), t = 4.13, p = 0.001,
age diﬀerence: b =−0.10 (95%. CI −0.28, 0.07), t =−1.28,
p = 0.22, N = 21, BN: age: b = 0.09 (95% CI 0.01, 0.19), t = 2.13,
p = 0.048, age diﬀerence: b =−0.02 (95%. CI −0.12, 0.08),
t =−0.51, p = 0.62, N = 20).
4. Discussion
The aim of this review was to synthesise the literature on alex-
ithymia in EDs using the TAS, a widely used self-report measure. A total
of 48 studies were identiﬁed through systematic review, 44 of which
were included in meta-analyses examining group diﬀerences in total
TAS scores. Twenty-two AN studies, 12 AN-R studies, six AN-BP studies,
21 BN studies and ﬁve BED studies were included in the meta-analyses.
There were signiﬁcant diﬀerences between all diagnostic groups and
HCs on the total TAS score with large eﬀect sizes, with the exception of
BED where the diﬀerence was with a medium eﬀect size. This indicates
that individuals across the spectrum of EDs have more diﬃculties with
identifying and describing their emotions than individuals without EDs.
When the individual subscale scores of the TAS-20 were analysed, in-
dividuals with AN scored signiﬁcantly higher on all subscales than HCs.
However, in studies where the AN subtype was deﬁned as AN-R and in
BN studies, the clinical group only scored higher on the Diﬃculty
Identifying Feelings and Diﬃculty Describing Feelings subscales. Due to
lack of data, it was not possible to examine subscale scores in in-
dividuals with AN-BP or BED.
There was evidence of publication bias in all diagnostic groups. This
may have been accounted for by the exclusion of any studies that did
not report both the mean and standard deviations of TAS scores.
Further attempt to contact the authors of such papers may have
therefore been beneﬁcial. In addition, methodological bias may have
impacted on the results. For example, a large proportion of studies had
a relatively small sample size, with very few accounting for this with a
power size calculation. When adjusting for publication bias, the eﬀect
sizes remained signiﬁcant, however, for BED the signiﬁcance dis-
appeared. Further studies examining alexithymia in individuals with
BED are therefore needed to conﬁrm whether they have real diﬃculties
with identifying and labelling emotions.
There were high levels of heterogeneity (74–82%) across studies. To
examine potential reasons for this heterogeneity, BMI of the clinical
group, diﬀerences in BMI between groups, age and age diﬀerences
Fig. 9. Forest plot of mean TAS score: standardized mean eﬀect
size for diﬀerences (SMD) between Bulimia Nervosa (BN) and
Healthy Controls. CI, conﬁdence interval.
Fig. 10. Forest plot of mean TAS score: standardized mean eﬀect
size for diﬀerences (SMD) between Binge Eating Disorder (BED)
and Healthy Controls. CI, conﬁdence interval.
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between groups were entered as moderator variables into meta-re-
gression. The BMI of the clinical groups did not inﬂuence the eﬀect size
for any of the ED diagnoses. In the AN analysis, there was a signiﬁcant
eﬀect of BMI diﬀerence between the clinical and HC group on eﬀect
size. There was also a signiﬁcant eﬀect of mean age of the clinical
groups on outcome in AN and BN studies, with older age of the clinical
group being associated with a larger eﬀect size.
The acute phase of AN is associated with reduced facial expression
of emotions compared with recovered patients [85], suggesting that
starvation may impact on alexithymia scores. As older patients may be
expected to have longer illness durations than younger patients, this
could explain why age was associated with a larger eﬀect size. It is also
possible that older patients experience more co-morbidities, including
Obsessive-Compulsive Disorder and depression, which are also asso-
ciated with alexithymia [2]. In the general population, alexithymia has
also been associated with increasing age [86]. Other reasons for the
large heterogeneity between studies include factors such as the level of
comorbid psychiatric conditions, such as anxiety or depression, which
could not be controlled for in meta-regression. There is also some evi-
dence that treatment outcome, or indeed the treatment which patients
receive, may be associated with levels of alexithymia in ED patients
[87] and thus the type of treatment patients in each of the studies were
receiving may have also accounted for some of the heterogeneity ob-
served.
Despite the large number of cross-sectional studies examining
alexithymia in EDs, longitudinal studies examining changes in TAS
scores overtime are lacking. One study [88] examined the predictive
value of alexithymia over three-years in patients with EDs. Using the
TAS-20, the DIF factor was a signiﬁcant predictor of treatment out-
come, independent of both depression and eating disorder severity. In
addition, there was signiﬁcant improvement in alexithymia scores,
along with improvement in clinical severity and depression, suggesting
that alexithymia may not be stable in individuals with EDs. The one
study identiﬁed in this review which included recovered patients [40]
found no signiﬁcant diﬀerence on TAS-20 scores between the clinical
and HC groups. This suggests that starvation, or the acute phase of AN
may impact on alexithymia. However, as illness duration was not in-
cluded in meta-regression, it is not possible to draw conclusions about
its impact on alexithymia in individuals with EDs.
Interestingly, while BMI of the clinical groups did not inﬂuence the
eﬀect size, in AN studies, the diﬀerence in BMI between the two groups
did have a signiﬁcant positive eﬀect on eﬀect size, with a greater dif-
ference in BMI being associated with a larger eﬀect size. This suggests
that BMI may be associated with alexithymia in AN although after
controlling for this, the main eﬀect was still signiﬁcant. Three studies
included in the AN meta-analysis [47,50,53] controlled for BMI in their
analysis and found that group diﬀerences remained signiﬁcant. There is
also a possibility that this is a chance result which would disappear
Fig. 11. Forest plot of mean TAS subscale scores: standardized
mean eﬀect size for diﬀerences (SMD) between Anorexia
Nervosa (AN) and Healthy Controls (HC). CI, conﬁdence in-
terval.
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after controlling for multiple testing. One previous study [89] found
that lower BMI was associated with decreased diﬃculties with emotion
regulation in women with acute AN. While emotion regulation is a
separate construct to alexithymia, with the former referring to the
ability to respond appropriately to situations with a range of emotions,
one might expect the two to be linked. Further research may therefore
be warranted to explore the impact of age, BMI and illness duration on
both alexithymia and emotional regulation.
Around half of the studies attempted to control for the eﬀect of
potentially confounding variables within the analysis of group
Fig. 12. Forest plot of mean TAS subscale scores: standardized
mean eﬀect size for diﬀerences (SMD) between Anorexia
Nervosa, Restricting subtype (AN-R) and Healthy Controls (HC).
CI, conﬁdence interval.
Fig. 13. Forest plot of mean TAS subscale scores: standardized
mean eﬀect size for diﬀerences (SMD) between Bulimia Nervosa
(BN) and Healthy Controls (HC). CI, conﬁdence interval.
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diﬀerences in TAS scores. Of the 19 studies which controlled for de-
pression, the diﬀerences in TAS scores between clinical and HC groups
only remained signiﬁcant in eight. In the eleven studies whose results
became insigniﬁcant after controlling for depression, eight were con-
ducted with individuals with AN (including AN-R and AN-BP). Six
studies [24,43–45,54,67] also controlled for anxiety within the ana-
lysis, however, so it is not possible to determine whether group dif-
ferences were inﬂuenced by depression, anxiety or both. Given the
previous literature suggesting a link between alexithymia and depres-
sion [e.g., 9], research aiming to elucidate the relationship between the
two constructs i.e., with inclusion of a clinical control group with de-
pression, would be beneﬁcial.
These meta-analyses indicate that diﬃculties with identifying and
describing emotions are transdiagnostic across the spectrum of EDs.
This is consistent with a previous systematic review of alexithymia [18]
and extends previous research by demonstrating that the diﬀerences
between clinical groups and HCs are of the same magnitude i.e., large
eﬀect sizes, across ED diagnoses. Nowakowski, McFarlane [18] found
that individuals with EDs score higher on the DIF and DDF subscales of
the TAS-20 but not on the EOT subscale. In this meta-analysis, in-
dividuals with AN were found to score signiﬁcantly higher on all sub-
scales, including the EOT whereas in AN-R studies and BN studies there
was no diﬀerence between groups on the EOT subscale. This suggests
that diﬃculties with EOT may be diagnosis-speciﬁc although further
research to conﬁrm this is warranted. Cronbach's alpha has been shown
to be lower for EOT than for the other two factors and both DDF and
DIF have low correlations with EOT, possibly due to low internal con-
sistency of this factor [90]. This may also explain the reason for the
inconsistent ﬁndings across EDs on the EOT subscale in these meta-
analyses.
Compared with other ED diagnoses, only ﬁve studies using the TAS
were identiﬁed in individuals with BED and it was not possible to
conduct subscale analysis on these studies, due to only two of them
[48,70] including subscale scores. Future research is therefore needed
to determine with diﬃculties across the TAS subscales are present in
BED. In addition, studies examining the presence of alexithymia in in-
dividuals who have recovered from an ED will help delineate the re-
lationship between alexithymia and ED psychopathology.
Despite individuals with EDs scoring signiﬁcantly higher than HCs,
it is still not clear whether the TAS is measuring a universal construct of
alexithymia or whether it is instead measuring other traits such as ne-
gative aﬀect, emotional expressivity or social shame [22–24]. Diﬀer-
ences in eﬀect size on the TAS-20 subscale scores indicate that the TAS
may be measuring several diﬀerent constructs and suggests that the
proposed three-factor model may not be suitable for use with ED po-
pulations [25]. Self-report measures such as the TAS may not be reliable
in that the very nature of alexithymia may make it diﬃcult for in-
dividuals to reﬂect on their emotions, thus giving inaccurate report. For
this reason, the development of tools which accurately assess the nature
of diﬃculties with emotion recognition using more objective measures
would be beneﬁcial. This would ensure that co-morbidities such as
anxiety or depression can be adequately controlled for in the assess-
ment of alexithymia and would allow for meaningful comparisons be-
tween clinical groups.
The Observer Alexithymia Scale [OAS; 91], an informant-report
measure, was developed as an alternative way of measuring alex-
ithymia and can be completed by either relatives or clinicians. In a
study examining the use of the OAS in an eating disorder population,
the measure showed acceptable validity and inter-rater reliability and
the OAS was recommended for use alongside the TAS-20 in both re-
search and clinical practice [92]. The psychometric properties of the
OAS have been tested across a range of psychiatric disorders and it was
found to be psychometrically sound for evaluating observer ratings of
alexithymia [93]. Despite this, correlation between the TAS-20 and
OAS is reportedly weak [94] and the authors do not recommend its use
in clinical settings. Thus, disagreement exists over exactly which
constructs the OAS and TAS are measuring. Another informant mea-
sure, the Toronto Structured Interview for Alexithymia [TSIA; 95] al-
lows for multi-modal assessment of alexithymia and was designed as a
tool for clinicians to elicit information about the extent of a patient's
diﬃculties with DIF, DDF, EOT and fantasy and imaginal processes.
When used with females with AN and their parents, there was sig-
niﬁcant discordance between the two measures, with suggestion that
the TSIA may be more sensitive for detecting alexithymia than the self-
report TAS-20 [96]. Further studies using the TSIA or other clinical-led
assessments across psychiatric populations would therefore help de-
termine whether such tools were measuring independent, related or
homogenous constructs.
The ﬁndings from the current meta-analysis add to the wider lit-
erature on socio-emotional diﬃculties in EDs. For example, a review
[97] used a multidimensional framework to map out emotion regula-
tion diﬃculties in AN and BN. The model [98] outlines four dimensions
theorised to contribute to the development or maintenance of psycho-
pathology: use of adaptive and situationally appropriate emotion reg-
ulation strategies; impulse inhibition and behavioural control when
distressed; emotional awareness, clarity, and acceptance; and emotional
approach and tolerance. There is evidence to suggest those with AN and
BN have diﬃculties across all four dimensions, however most relevant
here are diﬃculties with emotional awareness and acceptance, in-
cluding several constructs which overlap with alexithymia. For ex-
ample, using the Levels of Emotional Awareness Scale [LEAS; 99],
which asks individuals to report how they and another person would
feel in various scenarios, several studies have found impairments in
emotional awareness in the self and others in both EDs [44,100]. Stu-
dies using experimental paradigms such as the LEAS while controlling
for levels of alexithymia would help elucidate the relationships between
diﬀerent socio-emotional constructs in people with EDs.
Relatedly, emotional theory of mind, the ability to infer the emo-
tional states of others, is also reported to be impaired in AN and BN
[101,102], but may improve with recovery [100]. Facial emotion re-
cognition also appears to be impaired in AN (but not BN), although
results vary somewhat for diﬀerent emotions [103,104]. Finally, there
is evidence from both self-report and performance-based measures for
greater emotional suppression and non-acceptance in AN and BN
compared to controls [105–107]. Interestingly, this emotional sup-
pression appears to also be reﬂected in facial emotion expressivity, with
individuals with AN showing signiﬁcantly less positive emotions than
HCs, and BN showing an intermediate proﬁle [108]. Given the diﬃ-
culties in recognising ones' own emotions, it is perhaps not surprising
that those with EDs show widespread problems in decoding the emo-
tional states of others.
Given the diﬃculties that individuals with EDs have identifying and
describing emotions, clinical intervention has recently shifted focus on
addressing these issues. Certain treatment protocols including Cognitive
Remediation and Emotion Skills Training (CREST) have attempted to
address these diﬃculties in both individual and group format
[109,110], with preliminary ﬁndings suggesting that such treatment
leads to improvements in patients' ability to label emotions and a re-
duction in social anhedonia. The development of treatments such as
CREST are in their infancy and thus further studies assessing their ef-
ﬁcacy in reducing alexithymia are needed. Other treatment modalities
such as the Maudsley Model of Anorexia Nervosa Treatment in Adults
(MANTRA; Schmidt et al., 2015) and Radically Open Dialectical Be-
havioural Therapy (RO-DBT; Lynch et al., 2013) also include a focus on
emotional diﬃculties. Another relatively new treatment for EDs,
namely Emotion Acceptance Behaviour Therapy [EABT; 111], aims to
combine standard behavioural therapy with strategies to increase
emotional awareness and has been associated with decreased emotion
avoidance at follow-up. Measuring alexithymia before and after the
treatment will be beneﬁcial to explore the eﬀectiveness of these ap-
proaches on improving emotion recognition.
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4.1. Limitations
The studies varied greatly in terms of the mean age of participants,
mean BMI, mean illness duration of the clinical group, matching criteria
to HCs, recruitment sites, diagnostic tools and co-morbidities assessed.
This heterogeneity made direct comparison between studies diﬃcult.
Only six studies [46,50,52,80,112,113] fully reported all data extracted
for the purpose of this review. The variety of sociodemographic char-
acteristics, recruitment sites and diagnostic tools may have accounted
for some of the between-study heterogeneity found within the analysis,
although this could not be accounted for within analysis. Analysis of
risk of bias across studies indicated that smaller eﬀect sized studies with
less precision may be missing. There is a possibility that a small number
of studies were not identiﬁed through systematic review due to not
being published in English or full texts being unavailable.
5. Conclusion
Alexithymia, particularly diﬃculties with identifying and describing
emotions, is transdiagnostic across the ED spectrum. Our systematic
review of the literature, focusing on the TAS demonstrated that in-
dividuals with AN, BN and BED score consistently higher on the TAS
than HCs. Despite this, current instruments which measure alexithymia
may be inﬂuenced by co-morbid symptoms such as depression or an-
xiety and may not be measuring a homogenous construct. Recognising
and managing emotions are viable treatment targets. Future research
should focus on improving the measurement of this construct and on
the development of eﬀective clinical intervention to address diﬃculties
with emotional recognition.
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